Contrast-associated Acute Kidney Injury.

[1]  G. Chertow,et al.  Estimating the Risk of Radiocontrast-Associated Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[2]  J. Newhouse,et al.  Controversies in Contrast Material-induced Acute Kidney Injury: Closing in on the Truth? , 2015, Radiology.

[3]  D. Kallmes,et al.  Risk of Acute Kidney Injury, Dialysis, and Mortality in Patients With Chronic Kidney Disease After Intravenous Contrast Material Exposure. , 2015, Mayo Clinic proceedings.

[4]  Somjot S. Brar,et al.  Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial , 2014, The Lancet.

[5]  D. Kallmes,et al.  Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. , 2014, Radiology.

[6]  S. Villani,et al.  Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome). , 2014, Journal of the American College of Cardiology.

[7]  R. Mehran,et al.  Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. , 2014, Journal of the American College of Cardiology.

[8]  Grant D. Huang,et al.  Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[9]  J. Deckers,et al.  Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era. , 2013, Kidney international.

[10]  M. Tonelli,et al.  Renal outcomes associated with invasive versus conservative management of acute coronary syndrome: propensity matched cohort study , 2013, BMJ.

[11]  J. Bida,et al.  Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? , 2013, Radiology.

[12]  D. Kallmes,et al.  Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. , 2013, Radiology.

[13]  Act Investigators.  Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT) , 2011, Circulation.

[14]  P. Aspelin,et al.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines , 2011, European Radiology.

[15]  W. Qiu,et al.  Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials. , 2011, European journal of radiology.

[16]  R. Califf,et al.  2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[17]  Hani Jneid,et al.  2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in c , 2011, Journal of the American College of Cardiology.

[18]  E. Antman,et al.  2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[19]  Chi-yuan Hsu,et al.  Proteinuria and reduced glomerular filtration rate as risk factors for acute kidney injury , 2011, Current opinion in nephrology and hypertension.

[20]  M. Tonelli,et al.  Associations Between Acute Kidney Injury and Cardiovascular and Renal Outcomes After Coronary Angiography , 2011, Circulation.

[21]  M. Tonelli,et al.  Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. , 2010, Kidney international.

[22]  L. Wallentin,et al.  Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register , 2010, Journal of internal medicine.

[23]  R. Elosua,et al.  Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project. , 2010, Archives of internal medicine.

[24]  J. Spertus,et al.  Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography. , 2010, Journal of the American College of Cardiology.

[25]  M. Khamaisi,et al.  Reactive Oxygen Species and the Pathogenesis of Radiocontrast-Induced Nephropathy , 2010, Investigative radiology.

[26]  J. Kellum,et al.  Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  M. Jardine,et al.  Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy , 2009, Annals of Internal Medicine.

[28]  Jeremiah R. Brown,et al.  Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis. , 2009, JACC. Cardiovascular interventions.

[29]  Charles Davidson,et al.  Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures. , 2009, American heart journal.

[30]  G. Dangas,et al.  Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[31]  M. Mansournia,et al.  Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  B. Kristal,et al.  Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality. , 2009, The Israel Medical Association journal : IMAJ.

[33]  H. Gurm,et al.  The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. , 2009, JACC. Cardiovascular interventions.

[34]  Marino Labinaz,et al.  Contrast-induced nephropathy and long-term adverse events: cause and effect? , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[35]  M. Salarifar,et al.  N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial , 2009, Trials.

[36]  F. Turgut,et al.  Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials , 2009, International Urology and Nephrology.

[37]  Sonal Singh,et al.  Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  K. Okumura,et al.  Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide. , 2009, Journal of the American College of Cardiology.

[39]  J. Fine,et al.  Background fluctuation of kidney function versus contrast-induced nephrotoxicity. , 2009, AJR. American journal of roentgenology.

[40]  F. Veglia,et al.  Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality , 2009, Annals of Internal Medicine.

[41]  J. Roozbeh,et al.  A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial , 2009, International Urology and Nephrology.

[42]  D. Leung,et al.  Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N‐acetylcysteine and hydration before coronary angiography and intervention: a randomized trial , 2009, Internal medicine journal.

[43]  G. Breithardt,et al.  Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial. , 2008, The Canadian journal of cardiology.

[44]  Furman S. McDonald,et al.  Mortality associated with nephropathy after radiographic contrast exposure. , 2008, Mayo Clinic proceedings.

[45]  A. Shah,et al.  Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. , 2008, JAMA.

[46]  Jeremiah R. Brown,et al.  Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: Insights from the Dartmouth Dynamic Registry , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[47]  H. Gurm,et al.  Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. , 2008, American heart journal.

[48]  K. Ho,et al.  Use of Isotonic Sodium Bicarbonate to Prevent Radiocontrast Nephropathy in Patients with Mild Pre-Existing Renal Impairment: A Meta-Analysis , 2008, Anaesthesia and intensive care.

[49]  C. Nienaber,et al.  Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy , 2008, Coronary artery disease.

[50]  V. Guetta,et al.  Reversible Acute Kidney Injury following Contrast Exposure and the Risk of Long-Term Mortality , 2008, American Journal of Nephrology.

[51]  M. Leoncini,et al.  Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. , 2008, Journal of the American College of Cardiology.

[52]  H. Bachórzewska-Gajewska,et al.  NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine? , 2008, International journal of cardiology.

[53]  U. Schoepf,et al.  Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. , 2008, Radiology.

[54]  M. Fine,et al.  Prevention, incidence, and outcomes of contrast-induced acute kidney injury. , 2008, Archives of internal medicine.

[55]  S. de Servi,et al.  Impact of acute renal failure following percutaneous coronary intervention on long-term mortality , 2008, Journal of cardiovascular medicine.

[56]  K. Harjai,et al.  A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. , 2008, The American journal of cardiology.

[57]  S. Bernstein,et al.  Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy , 2008, Annals of Internal Medicine.

[58]  C. Natanson,et al.  A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity , 2007, BMC medicine.

[59]  K. Chou,et al.  Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. , 2007, Journal of the American College of Cardiology.

[60]  O. Aslan,et al.  Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. , 2007, American heart journal.

[61]  T. Morita,et al.  Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. , 2007, The American journal of cardiology.

[62]  Samin K. Sharma,et al.  Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.

[63]  J. Kaski,et al.  The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. , 2007, Journal of the American College of Cardiology.

[64]  A. Colombo,et al.  Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A Randomized Comparison of 3 Preventive Strategies , 2007, Circulation.

[65]  G. Breithardt,et al.  A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy , 2007, Clinical Research in Cardiology.

[66]  J. Núñez,et al.  Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial. , 2007, International journal of cardiology.

[67]  J. Tumlin,et al.  Economic burden of contrast-induced nephropathy: implications for prevention strategies , 2007, Journal of medical economics.

[68]  M. Fine,et al.  Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. , 2006, Journal of the American Society of Nephrology : JASN.

[69]  Charles Davidson,et al.  Risk prediction of contrast-induced nephropathy. , 2006, The American journal of cardiology.

[70]  Young‐Bae Park,et al.  Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. , 2006, Journal of the American College of Cardiology.

[71]  J. Brinker,et al.  A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. , 2006, Journal of the American College of Cardiology.

[72]  H. Bachórzewska-Gajewska,et al.  Neutrophil-Gelatinase-Associated Lipocalin and Renal Function after Percutaneous Coronary Interventions , 2006, American Journal of Nephrology.

[73]  F. Veglia,et al.  N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. , 2006, The New England journal of medicine.

[74]  P. Sager,et al.  Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate. , 2006, The American journal of cardiology.

[75]  Allen J. Taylor,et al.  Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics. , 2006, American heart journal.

[76]  W. Gibler,et al.  Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. , 2006, The American journal of medicine.

[77]  C. Sandhu,et al.  The Role of N-Acetylcysteine in the Prevention of Contrast-Induced Nephrotoxicity , 2006, CardioVascular and Interventional Radiology.

[78]  F. Veglia,et al.  Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. , 2006, The American journal of medicine.

[79]  H. Thomsen,et al.  ESUR guidelines on contrast media , 2006, Abdominal Imaging.

[80]  P. Aspelin,et al.  Contrast-medium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated gfr in ml/min , 2005, Acta radiologica.

[81]  R. Solomon.  The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. , 2005, Kidney international.

[82]  Samin K. Sharma,et al.  Effect of nonionic radiocontrast agents on the occurrence of contrast‐induced nephropathy in patients with mild‐moderate chronic renal insufficiency: Pooled analysis of the randomized trials , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[83]  C. Ting,et al.  Short- and long-term renal outcomes of immediate prophylactic hemodialysis after cardiovascular catheterizations in patients with severe renal insufficiency. , 2005, International journal of cardiology.

[84]  S. Bagshaw,et al.  Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. , 2005, Archives of internal medicine.

[85]  P. Nery,et al.  N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial , 2005, Heart.

[86]  D. Malenka,et al.  N‐acetylcysteine prophylaxis significantly reduces the risk of radiocontrast‐induced nephropathy: Comprehensive meta‐analysis , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[87]  M. Frey,et al.  Effectiveness of acetylcysteine in prevention of contrast nephropathy. , 2005, The Journal of invasive cardiology.

[88]  S. Pocock,et al.  Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. , 2005, Kidney international.

[89]  K. Shojania,et al.  Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. , 2004, The American journal of medicine.

[90]  D. Baker,et al.  Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine. , 2004, Journal of vascular surgery.

[91]  C. McCulloch,et al.  Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[92]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[93]  P. McLaughlin,et al.  N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up. , 2004, American heart journal.

[94]  D. Dunne,et al.  Exposure to malaria affects the regression of hepatosplenomegaly after treatment for Schistosoma mansoni infection in Kenyan children , 2004, BMC medicine.

[95]  W. Mcdougal.  Meta-Analysis of Randomized Clinical Trials on the Usefulness of Acetylcysteine for Prevention of Contrast Nephropathy , 2004 .

[96]  A. Levin,et al.  A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect. , 2004, American heart journal.

[97]  B. McNeil,et al.  "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. , 2004, Journal of the American Society of Nephrology : JASN.

[98]  A. Seguro,et al.  Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[99]  K. Harjai,et al.  Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. , 2004, The American journal of cardiology.

[100]  J. Boura,et al.  Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention. , 2004, Journal of interventional cardiology.

[101]  R. Bersin,et al.  Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.

[102]  J. Sanderson,et al.  Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[103]  M. Tonelli,et al.  Systematic review of the impact of N-acetylcysteine on contrast nephropathy. , 2004, Kidney international.

[104]  Christlieb Haller,et al.  The Cytotoxicity of Iodinated Radiocontrast Agents on Renal Cells In Vitro , 2004, Investigative radiology.

[105]  C. Poole,et al.  N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. , 2004, Journal of the American Society of Nephrology : JASN.

[106]  E. Schwammenthal,et al.  Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature. , 2004, European heart journal.

[107]  C. Hanet,et al.  Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient? , 2003, Acta cardiologica.

[108]  D. Hilleman,et al.  Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography. , 2003, American heart journal.

[109]  B. Macneill,et al.  Prophylaxis of contrast‐induced nephropathy in patients undergoing coronary angiography , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[110]  G. Stone,et al.  Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. , 2003, JAMA.

[111]  G. Marenzi,et al.  The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. , 2003, The New England journal of medicine.

[112]  W. Daniel,et al.  Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure. , 2003, Clinical nephrology.

[113]  F. Markowetz,et al.  Acetylcysteine for prevention of contrast nephropathy: meta-analysis , 2003, The Lancet.

[114]  P. Aspelin,et al.  Nephrotoxic effects in high-risk patients undergoing angiography. , 2003, The New England journal of medicine.

[115]  Chi‐Hang Lee,et al.  Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. , 2003, JAMA.

[116]  G. Stewart,et al.  The Curious Genomic Path from Leaky Red Cell to Nephrotic Kidney , 2003, Nephron Physiology.

[117]  A. Agrawal,et al.  A Randomized Prospective Trial to Assess the Role of Saline Hydration on the Development of Contrast Nephrotoxicity , 2003, Nephron Clinical Practice.

[118]  S. Fishbane,et al.  A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. , 2002, Kidney international.

[119]  S. Allaqaband,et al.  Prospective randomized study of N‐acetylcysteine, fenoldopam, and saline for prevention of radiocontrast‐induced nephropathy , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[120]  K. Shyu,et al.  Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. , 2002, Journal of the American College of Cardiology.

[121]  M. Classen,et al.  Haemodialysis for the Prevention of Contrast-Induced Nephropathy: Outcome of 31 Patients With Severely Impaired Renal Function, Comparison With Patients at Similar Risk and Review , 2002, Investigative radiology.

[122]  I. Hizoh,et al.  Radiocontrast-Induced Renal Tubular Cell Apoptosis: Hypertonic Versus Oxidative Stress , 2002, Investigative radiology.

[123]  B. Villari,et al.  Acetylcysteine and contrast agent-associated nephrotoxicity. , 2002, Journal of the American College of Cardiology.

[124]  Kirk N. Garratt,et al.  Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.

[125]  S. Marsch,et al.  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002, Archives of internal medicine.

[126]  C. Schnackenberg.  Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[127]  Douglas Losordo,et al.  Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). , 2002, The American journal of cardiology.

[128]  S. Hagl,et al.  Poly(ADP-Ribose) Polymerase Inhibition Reduces Reperfusion Injury After Heart Transplantation , 2002, Circulation research.

[129]  Kontrastmittelinduziertes Nierenversagen lässt sich durch Hämodialyse nicht verhindern , 2002 .

[130]  D. Weaver,et al.  Use of fenoldopam to prevent radiocontrast nephropathy in high‐risk patients , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[131]  H. Madyoon,et al.  Use of fenoldopam for prevention of radiocontrast nephropathy in the cardiac catheterization laboratory: a case series. , 2001, Journal of interventional cardiology.

[132]  L. Baker,et al.  Prevention of contrast nephropathy after cardiac catheterisation , 2001, Heart.

[133]  G. Dangas,et al.  The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. , 2000, Journal of the American College of Cardiology.

[134]  W Zidek,et al.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.

[135]  M. Brezis,et al.  Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia. , 1999, Investigative radiology.

[136]  G. Bakris,et al.  Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors. , 1999, Kidney international.

[137]  N. Chalmers,et al.  Comparison of iodixanol and iohexol in renal impairment. , 1999, The British journal of radiology.

[138]  M. Leon,et al.  Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. , 1999, The American journal of cardiology.

[139]  M. Epstein,et al.  Potential of dopamine A-1 agonists in the management of acute renal failure. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[140]  W. Kübler,et al.  Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[141]  E. Bates,et al.  Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[142]  J. Kellum.  Systematic review: The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence , 1997, Critical care.

[143]  W. O’Neill,et al.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.

[144]  T. Risler,et al.  Prevention of radiocontrast-induced nephropathy by adenosine antagonists in rats with chronic nitric oxide deficiency. , 1997, Journal of the American Society of Nephrology : JASN.

[145]  C. Viscoli,et al.  The effect of acute renal failure on mortality. A cohort analysis. , 1996, JAMA.

[146]  M. Rudnick,et al.  Contrast media-associated nephrotoxicity. , 1996, Current opinion in nephrology and hypertension.

[147]  N. Sinha,et al.  Use of dopamine in prevention of contrast induced acute renal failure--a randomised study. , 1996, International journal of cardiology.

[148]  G. Taylor,et al.  Nephrotoxicity from contrast media: attenuation with theophylline. , 1995, Radiology.

[149]  A. P. Shapiro,et al.  The Effect of Prophylactic Nifedipine on Renal Function in Patients Administered Contrast Media , 1995, Pharmacotherapy.

[150]  J. D'Elia,et al.  Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. , 1994, The New England journal of medicine.

[151]  B. Barrett,et al.  Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. , 1993, Radiology.

[152]  V. Bernhard,et al.  Contrast-induced nephrotoxicity: the effects of vasodilator therapy. , 1992, The Journal of surgical research.

[153]  A. Fogo,et al.  Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. , 1992, Kidney international.

[154]  M. Brezis,et al.  Early renal medullary hypoxic injury from radiocontrast and indomethacin. , 1991, Kidney international.

[155]  Y. Wang,et al.  Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. , 1990, The American journal of medicine.

[156]  G. Bakris,et al.  Oxygen free radical involvement in urinary Tamm-Horsfall protein excretion after intrarenal injection of contrast medium. , 1990, Radiology.

[157]  R. Moncada,et al.  Contrast media-induced lipid peroxidation in the rat kidney. , 1989, Investigative radiology.

[158]  L. Hillis,et al.  Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. , 1989, The American journal of medicine.

[159]  P. Parfrey,et al.  Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. , 1989, The New England journal of medicine.

[160]  H. Humes,et al.  Direct toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells. , 1987, The American journal of physiology.

[161]  L. Fisher,et al.  Risks for renal dysfunction with cardiac angiography. , 1986, Annals of internal medicine.

[162]  A. Gomes,et al.  Acute renal dysfunction after major arteriography. , 1985, AJR. American journal of roentgenology.

[163]  T. Hutchinson,et al.  Renal function following infusion of radiologic contrast material. A prospective controlled study. , 1985, Archives of internal medicine.

[164]  J. P. Valette,et al.  Transient glomerular proteinuria, enzymuria, and nephrotoxic reaction induced by radiocontrast media. , 1984, JAMA.

[165]  R. Gleason,et al.  Nephrotoxicity from angiographic contrast material. A prospective study. , 1982, The American journal of medicine.

[166]  P. Jungers,et al.  Tubular Nephrotoxicity of Water‐soluble Iodinated Contrast Media , 1980, Investigative radiology.

[167]  T. Shafi,et al.  Role of N-Acetylcysteine in Prevention of Contrast Induced Nephropathy , 2016 .

[168]  C. Ronco,et al.  Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review. , 2012, The American journal of medicine.

[169]  Fei He,et al.  Risk factors and outcomes of acute kidney injury after intracoronary stent implantation. , 2012, World journal of emergency medicine.

[170]  F. Veglia,et al.  Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. , 2012, JACC. Cardiovascular interventions.

[171]  S. Pornratanarangsi,et al.  Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio. , 2010, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[172]  W. Bautz,et al.  Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. , 2009, Radiology.

[173]  S. Weisbord,et al.  Prevention of contrast-induced nephropathy with volume expansion. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[174]  S. Cowper,et al.  Nephrogenic systemic fibrosis: an overview. , 2008, Journal of the American College of Radiology : JACR.

[175]  M. Joannidis,et al.  Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis , 2008, Wiener klinische Wochenschrift.

[176]  Luis S Cremona,et al.  Renoprotective effect of high periprocedural doses of oral N-acetylcysteine in patients scheduled to undergo a same-day angiography. , 2004, Revista de la Facultad de Ciencias Medicas.

[177]  B. Jaber,et al.  Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[178]  Vandana S. Mathur.  The role of the DA1 receptor agonist fenoldopam in the management of critically ill, transplant, and hypertensive patients. , 2003, Reviews in cardiovascular medicine.

[179]  G. Marenzi,et al.  Marenzi, G. et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N. Engl. J. Med. 349, 1333-1340 , 2003 .

[180]  J. Beitz,et al.  Renal Failure Associated with the Use of Celecoxib and Rofecoxib , 2002, Drug safety.

[181]  R. Katholi,et al.  Proximal tubule cell response to radiographic contrast media. , 2001, American journal of physiology. Renal physiology.

[182]  H. Madyoon.  Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients. , 2001, Reviews in cardiovascular medicine.

[183]  M. Cova,et al.  Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial , 1998, European Radiology.

[184]  E. Halpern,et al.  Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. , 1995, Kidney international.

[185]  P. Kurnik,et al.  Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. , 1994, Kidney international.

[186]  P. Kurnik,et al.  Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. , 1993, Renal failure.

[187]  M. Brezis,et al.  Potential deleterious effect of furosemide in radiocontrast nephropathy. , 1992, Nephron.

[188]  G. Bakris,et al.  Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. , 1990, The American journal of physiology.

[189]  M. Grisham,et al.  Cytotoxic properties of salivary oxidants. , 1990, The American journal of physiology.

[190]  T. Risler,et al.  Nephrology Dialysis Transplantation Prevention of Radiocontrast-media-induced Nephropathy in Patients with Pre-existing Renal Insufficiency by Hydration in Combination with the Adenosine Antagonist Theophylline , 2022 .